TNF Pharmaceuticals (TNFA) Competitors $0.11 +0.00 (+2.64%) Closing price 04:00 PM EasternExtended Trading$0.11 0.00 (-2.75%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock TNFA vs. ORGS, XBIO, ATNF, CYCC, ENSC, GLTO, KTTA, ALBT, APM, and MTNBShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Orgenesis (ORGS), Xenetic Biosciences (XBIO), 180 Life Sciences (ATNF), Cyclacel Pharmaceuticals (CYCC), Ensysce Biosciences (ENSC), Galecto (GLTO), Pasithea Therapeutics (KTTA), Avalon GloboCare (ALBT), Aptorum Group (APM), and Matinas Biopharma (MTNB). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Its Competitors Orgenesis Xenetic Biosciences 180 Life Sciences Cyclacel Pharmaceuticals Ensysce Biosciences Galecto Pasithea Therapeutics Avalon GloboCare Aptorum Group Matinas Biopharma Orgenesis (NASDAQ:ORGS) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability. Does the media prefer ORGS or TNFA? In the previous week, TNF Pharmaceuticals had 2 more articles in the media than Orgenesis. MarketBeat recorded 2 mentions for TNF Pharmaceuticals and 0 mentions for Orgenesis. TNF Pharmaceuticals' average media sentiment score of 1.24 beat Orgenesis' score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Orgenesis Neutral TNF Pharmaceuticals Positive Is ORGS or TNFA more profitable? TNF Pharmaceuticals has a net margin of 0.00% compared to Orgenesis' net margin of -3,827.81%. Orgenesis' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Orgenesis-3,827.81% N/A -130.18% TNF Pharmaceuticals N/A -97.38%-37.37% Which has more volatility and risk, ORGS or TNFA? Orgenesis has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500. Comparatively, TNF Pharmaceuticals has a beta of 1.98, meaning that its share price is 98% more volatile than the S&P 500. Do institutionals & insiders hold more shares of ORGS or TNFA? 22.6% of Orgenesis shares are held by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are held by institutional investors. 5.7% of Orgenesis shares are held by company insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation and earnings, ORGS or TNFA? TNF Pharmaceuticals has lower revenue, but higher earnings than Orgenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrgenesis$662K8.12-$55.36MN/AN/ATNF PharmaceuticalsN/AN/A-$23.36M-$6.67-0.02 SummaryTNF Pharmaceuticals beats Orgenesis on 6 of the 10 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.51M$2.42B$5.52B$9.32BDividend YieldN/A1.79%4.25%4.05%P/E Ratio-0.029.1828.1519.68Price / SalesN/A737.05438.33100.29Price / CashN/A160.6835.5357.53Price / Book0.044.698.235.67Net Income-$23.36M$30.99M$3.23B$257.51M7 Day Performance-13.70%0.60%-0.01%0.52%1 Month Performance-25.34%7.93%5.61%8.84%1 Year PerformanceN/A-5.48%26.52%14.18% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$0.11+2.6%N/AN/A$1.51MN/A-0.026Positive NewsGap UpHigh Trading VolumeORGSOrgenesisN/A$1.18+10.3%N/AN/A$5.66M$662K0.00150XBIOXenetic Biosciences1.0654 of 5 stars$3.66-8.0%N/A-13.0%$5.64M$2.50M-1.544Gap UpATNF180 Life Sciences0.7793 of 5 stars$0.90-0.7%N/A-56.0%$5.44MN/A-0.067News CoverageCYCCCyclacel Pharmaceuticals1.2348 of 5 stars$3.31-10.8%N/A-97.0%$5.25M$14K0.0014Trending NewsGap DownENSCEnsysce Biosciences0.6137 of 5 stars$2.20+1.9%N/A-69.5%$5.22MN/A-0.3410News CoverageGLTOGalecto3.2229 of 5 stars$3.90+10.2%$10.00+156.4%-76.0%$5.15MN/A-0.2540KTTAPasithea Therapeutics1.6205 of 5 stars$0.69+0.1%N/A-88.7%$5.14MN/A-0.073ALBTAvalon GloboCare1.3415 of 5 stars$2.71+6.3%N/A-63.0%$5.13M$1.37M-0.145News CoverageHigh Trading VolumeAPMAptorum Group2.0649 of 5 stars$0.95+1.2%N/A-77.5%$5.10M$430K0.0030News CoverageGap DownTrading HaltedMTNBMatinas BiopharmaN/A$1.00-2.9%N/AN/A$5.09MN/A-0.2130 Related Companies and Tools Related Companies Orgenesis Alternatives Xenetic Biosciences Alternatives 180 Life Sciences Alternatives Cyclacel Pharmaceuticals Alternatives Ensysce Biosciences Alternatives Galecto Alternatives Pasithea Therapeutics Alternatives Avalon GloboCare Alternatives Aptorum Group Alternatives Matinas Biopharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
